Source: International Congress 2014 – Lung function, COPD and inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Akiki, D. Fakih, R. Jounblat, S. Chamat, M. Waked, G. Sorensen, R. Nadif, P. Salameh (Villejuif, France; Fanar, Beirut, Hadath, Lebanon; Odense, Denmark). SP-D as a biomarker for COPD in the Lebanese population. Eur Respir J 2014; 44: Suppl. 58, 4767

Member's Comments

No comment yet.

Related content which might interest you: Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Proteinase-inhibitor system state in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 COPD prevalence in Argentina: The EPOC.AR study Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Variants of apelin gene and COPD Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Comorbidities and burden of COPD: A population based case-control study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Cardiovascular comorbidities of COPD in never-smokers Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014 Identification of clinical phenotypes in patients with and without COPD using cluster analysis Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Defining asthma COPD overlap syndrome (ACOS): A population based study Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Adrenomedullin optimizes mortality prediction in COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Symptoms of COPD in the general population are associated with overweight and obesity Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Role of tuberculosis in COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015